Skip to main content
Clinical Trials/NCT02869412
NCT02869412
Completed
N/A

A Physical Activity Behavior Change Guide for Prostate Cancer Patients (iTRAIN Study)

OHSU Knight Cancer Institute1 site in 1 country56 target enrollmentJanuary 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prostate Carcinoma
Sponsor
OHSU Knight Cancer Institute
Enrollment
56
Locations
1
Primary Endpoint
Change in self efficacy for exercise, assessed by the Self Efficacy for Exercise questionnaire (Evaluation Phase)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This randomized pilot clinical trial studies how well a computer-based behavior change guide works in increasing physical activity in patients with prostate cancer who have received androgen deprivation therapy. A computer-based behavior change guide website may increase physical activity level for prostate cancer survivors and help doctors understand what outcomes related to becoming physically active are most important to patients with prostate cancer.

Detailed Description

PRIMARY OBJECTIVES: I. Engage with prostate cancer patients (PCPs) who have received or are currently on androgen deprivation therapy (ADT) to develop a computer-based behavior change guide (BCG) for PCPs to provide fundamental information about benefits of exercise for their individual capabilities and goals and provide a personalized physical activity plan. (Development Phase) II. Engage with PCPs to understand what outcomes are most important to them related to becoming active (e.g., helped me manage side-effects of treatment, reduced fatigue) and develop measures to evaluate these patient-centered outcomes. (Development Phase) III. Evaluate the BCG in a study comparing the personalized computer-based BCG with physical activity recommendations provided via a passive website (American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Survivors) among PCPs who have received ADT. (Evaluation Phase) OUTLINE: DEVELOPMENT PHASE: Patients view mock-ups of the BCG web design on a computer, iPad, or printed color paper and provide feedback with a one-on-one interview or separately using the think/talk aloud method followed by a one-on-one interview. After completion of these design rounds, patients use the BCG website and provide individual feedback. EVALUATION PHASE: Patients are randomized to 1 of 2 groups. GROUP I: Patients use the BCG website which will collect personal information including individual health priorities/goals, demographics (i.e. age, ethnicity), health information (i.e. weight, height, cancer history, other health conditions), individual capabilities, physical activity level, and exercise preferences. Patients then receive a report with a personalized physical activity plan. GROUP II: Patients use a passive website (American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Survivors). After completion of study, patients are followed up at 2 months.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
July 31, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Esther Moe

Principal Investigator

OHSU Knight Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Prostate cancer (PCa) diagnosis
  • Able to read English on a computer screen
  • Signed an Institutional Review Board (IRB)-approved informed consent
  • EVALUATION PHASE
  • Underactive (defined as physically active for less than 30 minutes per day fewer than 2 days per week)
  • Access to a computer at home or public location

Exclusion Criteria

  • Non-English speaking subjects are excluded from this study; the website being developed will only be available in English

Outcomes

Primary Outcomes

Change in self efficacy for exercise, assessed by the Self Efficacy for Exercise questionnaire (Evaluation Phase)

Time Frame: Baseline up to 2 months

For the qualitative characteristics collected, univariate summaries (e.g., frequency counts and proportions) will be calculated. For quantitative characteristics, means, standard deviations, medians, and ranges will be computed. The analysis will be conducted as an intent-to-treat efficacy assessment comparing the two interventions. Analyses will examine changes between baseline and follow-up scores on outcome measures by group. Comparisons will be conducted using Generalized Estimating Equations (GEE) with robust (sandwich) variance estimates.

Stage of change for exercise, assessed by the Stage of Change for Exercise questionnaire (Evaluation Phase)

Time Frame: Up to 2 months

For the qualitative characteristics collected, univariate summaries (e.g., frequency counts and proportions) will be calculated. For quantitative characteristics, means, standard deviations, medians, and ranges will be computed. The analysis will be conducted as an intent-to-treat efficacy assessment comparing the two interventions. Analyses will examine changes between baseline and follow-up scores on outcome measures by group. Comparisons will be conducted using GEE with robust (sandwich) variance estimates.

Website usability, assessed by qualitative evaluation of interviews and feedback (Development Phase)

Time Frame: Up to 9 months

Secondary Outcomes

  • Body weight(Baseline up to 2 months)
  • Average activity level for seniors per Community Healthy Activity Model Program for Seniors (CHAMPS) questionnaire(Baseline up to 2 months)
  • Measurement of exercise motivation using the Behavioral Regulation In Exercise Questionnaire (BREQ)(Baseline up to 2 months)
  • Measurement of fatigue using the Piper Fatigue Scale(Baseline up to 2 months)
  • Measurement of quality of life per European Organization for Research and Treatment of Cancer (EORTC) Quality Of Life Questionnaire-core 30 (QLQ-C30) questionnaire(Baseline up to 2 months)
  • Self-reported physical activity assessed by the Rapid Assessment of Physical Activity (RAPA)(Baseline up to 2 months)
  • Website use and acceptability assessed by questionnaire(Responses collected at 2 months)

Study Sites (1)

Loading locations...

Similar Trials